Understand the source comparison
VIP News 2026: Research-Grade Peptides Comparison
Understanding where VIP fits among immune-modulating and neuroprotective peptides helps researchers select the right tool for specific pathways. The following table compares VIP with closely related research peptides based on mechanism, half-life, primary appl
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Understanding where VIP fits among immune-modulating and neuroprotective peptides helps researchers select the right tool for specific pathways. The following table compares VIP with closely related research peptides based on mechanism, half-life, primary applications, and practical considerations for lab use.
- VIP
- VPAC1/VPAC2 receptor agonist; increases cAMP, suppresses NF-κB, promotes Treg differentiation
- 60–90 seconds
- Neuroinflammation, autoimmune models (EAE, IBD), circadian rhythm studies
- Store lyophilized at −20°C; reconstitute with bacteriostatic water; use within 28 days at 2–8°C
- Best for studies requiring simultaneous CNS and peripheral immune modulation; short half-life limits systemic use
- Thymosin Alpha-1
- TLR agonist; enhances dendritic cell maturation, upregulates IFN-α/β
- 2–3 hours
- Immunosenescence, viral infection models, cancer immunotherapy adjuvant research
- Store lyophilized at −20°C; stable up to 36 months; reconstitute immediately before use
- Ideal for innate immunity and antigen presentation studies; longer half-life than VIP allows dosing flexibility
- KPV
- Melanocortin receptor interaction; inhibits NF-κB and MAPK pathways
- <10 minutes
- Inflammatory bowel disease models, wound healing, localized inflammation
- Store at −20°C; highly susceptible to oxidation; use fresh reconstitutions
- Potent anti-inflammatory in gut tissue; tripeptide structure limits stability but enhances tissue penetration
- ARA 290
- Innate repair receptor agonist; activates tissue-protective pathways without erythropoiesis
- 4–6 hours
- Neuropathy models, ischemic injury, metabolic dysfunction
- Store at 2–8°C after reconstitution; light-sensitive; protect from photodegradation
- Unique for tissue repair without hematopoietic side effects; effective in small-fiber neuropathy models
- Selank
- Modulates BDNF expression; anxiolytic through GABAergic system enhancement
- 20–30 minutes
- Anxiety models, cognitive function, stress response
- Store lyophilized at −20°C; acetate salt form offers better stability than free peptide
- Best for studies linking immune modulation to anxiety and learning; synthetic analog of tuftsin
- VIP stands out for receptor specificity and dual-site action. It's the only peptide in this group that simultaneously modulates CNS microglia and peripheral immune cells through the same signaling pathway. The trade-off is the extremely short half-life, which makes VIP impractical for systemic administration studies but ideal for in vitro work, ex vivo tissue models, and intranasal or intracerebroventricular (ICV) routes where the peptide reaches target tissue before degradation.